Corteva, Inc.CTVA
Corteva, Inc. Financial Overview 2021–2025
Corteva's income from continuing operations surged to $1.2 billion in FY2025—a substantial leap from $863 million the prior year—signaling the success of strict cost-cutting and pricing discipline. Despite ongoing macroeconomic volatility, the agricultural chemical provider has proven its ability to defend profitability, paving the way for a major strategic unlock: separating its Seed and Crop Protection segments into two standalone businesses by late 2026.
Over the last five years, the company expanded net sales from $15.66 billion in FY2021 to $17.4 billion in FY2025. This top-line expansion was fueled by a persistent pricing strategy and a 3% volume increase that successfully offset unfavorable currency impacts. Operational execution was highly effective, with Cost of Goods Sold dropping to $9.2 billion in FY2025 due to raw material deflation and targeted productivity initiatives. Consequently, Operating EBITDA climbed 14% year-over-year to reach $3.8 billion. Innovation spending also accelerated, with research and development investments hitting $1.5 billion.
Management has consistently prioritized returning cash, deploying $1.5 billion through share repurchases and dividends in FY2025. This buyback activity steadily reduced the outstanding share count from 0.73 billion in FY2021 to 0.67 billion by the end of FY2025. The market recognized this combination of margin expansion and capital discipline. At the close of FY2025, the stock traded at $67.03, giving the company a $45.1 billion market capitalization and a 41.9x price-to-earnings multiple.
Recent Developments (Q3 and Q4 2025)
In Q3 2025, Corteva reported a 13% year-over-year revenue increase to $2.62 billion, driven by a 12% surge in volume. This top-line expansion reduced the quarterly net loss to $320 million, compared to a $524 million deficit in the prior year. The Seed segment led this growth, expanding 33% in the third quarter on early Brazil deliveries and an Argentina recovery, while Crop Protection sales grew 4%. Operationally, the company structured its upcoming business split as a tax-free spin-off and appointed Jennifer A. Johnson as Chief Legal Officer in September 2025.
Bulls emphasize the third-quarter volume recovery in Latin America despite a 1% pricing decline. Bears point to creeping overhead costs, with annual SG&A expenses rising to 20% of net sales, alongside a valuation of 46.3x trailing earnings at a $49.8 billion market capitalization as of February 11, 2026.
What to watch: progress on the tax-free spin-off execution; further volume momentum in South American seed markets.
Rev
$17.40B
FY2025
NI
$1.09B
FY2025
EPS
$1.60
FY2025
OCF
$3.41B
FY2025
Year-over-year comparison from 10-K annual reports
Data from SEC Company Facts
Recent SEC Filings
Corteva, Inc. 8-K Report, Financial Results (Feb 3, 2026)
Corteva, Inc. (CTVA) has filed an 8-K on February 3, 2026, to report its financial results for the quarter and full year ended December 31, 2025. While the filing itself is brief and primarily an informational update, it signifies the release of the company's detailed financial performance for the period. Investors should refer to the furnished exhibits, specifically the Press Release (Exhibit 99.1) and Financial Statement Schedules (Exhibit 99.2), for comprehensive insights into the company's revenue, profitability, and other key financial metrics for the fiscal year 2025.
Corteva, Inc. 8-K Report, Financial Results (Nov 4, 2025)
Corteva, Inc. (CTVA) has filed a Form 8-K on November 3, 2025, reporting its financial results for the quarter ended September 30, 2025. The filing primarily serves to announce these results, which are detailed in an accompanying press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2). Investors should note that this information is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it does not carry the same liability implications, nor will it be automatically incorporated into future SEC filings unless explicitly referenced. While the specifics of the financial performance are contained within the exhibits, this 8-K signals the release of key quarterly data. Investors interested in Corteva's operational performance, profitability, and financial condition for the third quarter of 2025 will need to review the furnished press release and financial statements. The filing is a standard procedural step for publicly traded companies to disseminate material financial information to the market.
Corteva, Inc. 8-K Report, Financial Results (Oct 1, 2025)
Corteva, Inc. (CTVA) has announced a significant strategic move to separate into two independent, publicly traded companies via a tax-free spin-off, as detailed in their 8-K filing dated October 1, 2025. This decision marks a pivotal moment for the company, aiming to unlock greater value and strategic focus for each new entity. Investors should pay close attention to the details of this separation as it will reshape the company's structure and potentially its market position. Further details regarding the spin-off and commentary on expected 2025 financial performance will be discussed during an investor call scheduled for October 1, 2025. While the specific financial outcomes of the separation are yet to be fully disclosed, the intent to create two distinct entities suggests a move towards enhancing operational efficiency, pursuing specialized growth strategies, and providing clearer investment profiles for each business segment. Investors will be looking for information on the go-to-market strategies and financial projections for both new companies.
Corteva, Inc. 8-K Report, Executive Changes (Aug 26, 2025)
Corteva, Inc. announced a significant leadership transition within its legal and public affairs functions. Cornel Fuerer, Senior Vice President, Chief Legal and Public Affairs Officer, will retire from his executive officer role effective September 15, 2025. While Mr. Fuerer will transition his public affairs oversight and corporate secretary duties to his successor by the end of 2025, he will continue to serve as a strategic advisor until sometime in 2026, ensuring a smooth handover. Taking over the Chief Legal Officer role is Jennifer A. Johnson, a seasoned legal executive with extensive experience in the chemical and life sciences industries. Her background includes significant roles at International Flavors & Fragrances Inc. (IFF) and DuPont de Nemours, Inc., where she gained direct experience with Corteva's former parent company and its seed business. This appointment signals a focus on strengthening the company's legal and compliance framework.
Corteva, Inc. 8-K Report, Financial Results (Aug 6, 2025)
Corteva, Inc. (CTVA) has filed an 8-K report on August 6, 2025, to announce its financial results for the second quarter ended June 30, 2025. The filing includes a press release and financial statement schedules, furnished as exhibits. This report provides investors with an update on the company's operational and financial performance during the recently concluded quarter. Investors should refer to the furnished exhibits (99.1 and 99.2) for detailed financial information, including revenue, earnings, segment performance, and any forward-looking guidance. While this information is being furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, it is crucial for understanding Corteva's recent financial health and strategic positioning in the agricultural sector.
View all 8-K filings →